The Latest Cardiac and Vascular News
DURHAM, N.C.–(BUSINESS WIRE)–Please replace the release dated January 24, 2018, with the following corrected version due to multiple revisions. The corrected release reads: FIRST PATIENT ENROLLED IN TRYTON POST APPROVAL STUDY The only FDA approved device to treat coronary bifurcations […]
DURHAM, N.C.–(BUSINESS WIRE)– Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company has appointed Carl J. St. Bernard as president and chief executive officer. St. Bernard has a long track record […]
DURHAM, N.C.–(BUSINESS WIRE)– Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced that the first U.S. commercial case using the Tryton Side Branch Stent to treat a coronary bifurcation lesion involving a large […]
